Related Experiment Video
Updated: Feb 24, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Fate-Regulating Circuits in Viruses: From Discovery to New Therapy Targets
Anand Pai1, Leor S Weinberger1,2
1Gladstone Institute of Virology and Immunology, San Francisco, California 94158;
Abstract:
Current antivirals effectively target diverse viruses at various stages of their life cycles. Nevertheless, curative therapy has remained elusive for important pathogens, such as human immunodeficiency virus type 1 (HIV-1) and herpesviruses, in large part due to viral latency and the evolution of resistance to existing therapies. Here, we review the discovery of viral master circuits: virus-encoded autoregulatory gene networks that autonomously control viral expression programs (i.e., between active, latent, and abortive fates). These circuits offer the opportunity for a new class of antivirals that could lead to intrinsic combination-antiviral therapies within a single molecule-evolutionary escape from such circuit-disrupting antivirals would require simultaneous evolution of both the viral cis regulatory element (e.g., the DNA-binding site) and the trans element (e.g., the transcription factor) in order for the virus to recapitulate a circuit that would not be disrupted. We review the architectures of these fate-regulating master circuits in HIV-1 and the human herpesvirus cytomegalovirus along with potential circuit-disruption strategies that may ultimately enable escape-resistant antiviral therapies.
Insights
New antivirals targeting viral master circuits could overcome resistance. These circuits control viral activity, offering a novel strategy for durable therapies against viruses like HIV-1 and herpesviruses.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Current antiviral therapies face challenges with viral latency and resistance.
- Pathogens like human immunodeficiency virus type 1 (HIV-1) and herpesviruses remain difficult to cure.
- Viral latency and drug resistance limit the effectiveness of existing treatments.
Purpose of the Study:
- To review the discovery and significance of viral master circuits.
- To explore the potential of targeting these circuits for novel antiviral therapies.
- To discuss strategies for developing escape-resistant treatments against persistent viral infections.
Main Methods:
- Review of existing literature on viral gene networks and regulatory circuits.
- Analysis of master circuit architectures in HIV-1 and human herpesvirus cytomegalovirus (CMV).
- Exploration of potential strategies to disrupt viral master circuits.
Main Results:
- Viral master circuits are virus-encoded autoregulatory gene networks controlling viral expression fates (active, latent, abortive).
- Disrupting these circuits offers a new class of antivirals with intrinsic combination therapy potential.
- Simultaneous evolution of cis and trans elements is required for viral escape from circuit-disrupting antivirals.
Conclusions:
- Viral master circuits represent a promising target for developing novel antiviral strategies.
- Targeting these circuits may lead to therapies that are more resistant to viral evolution and escape.
- This approach holds potential for achieving curative therapies against challenging viruses like HIV-1 and CMV.
Related Concept Videos
Retrovirus Life Cycles
Viruses with RNA Genomes
Microorganisms in Medicine and Therapeutics
Mechanisms of Retrovirus-induced Cancers
Leaky Scanning
Size and Structure of Viral Genomes

